4//SEC Filing
Quinn William P. 4
Accession 0001193125-25-250332
CIK 0001641281other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 7:18 PM ET
Size
6.7 KB
Accession
0001193125-25-250332
Insider Transaction Report
Form 4
Quinn William P.
DirectorPresident, CEO and CFO
Transactions
- Purchase
Common Stock
2025-06-06$5.49/sh+125$687→ 2,188 total - Award
Common Stock
2025-10-22+40,000→ 42,188 total
Footnotes (3)
- [F1]Shares acquired under the issuer's Employee Stock Purchase Plan and therefore exempt under Rule 16b-3(c)
- [F2]The shares represent restricted stock units that were received as an award, for no consideration. Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F3]The restricted stock units subject to the award will vest in full on September 15, 2026, assuming continued employment through such date.
Documents
Issuer
Bolt Biotherapeutics, Inc.
CIK 0001641281
Entity typeother
Related Parties
1- filerCIK 0001724190
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 7:18 PM ET
- Size
- 6.7 KB